$10.30
6.36% yesterday
Nasdaq, Nov 15, 09:50 pm CET
ISIN
US21900C3088
Symbol
CRMD

CorMedix Inc Target price 2024 - Analyst rating & recommendation

CorMedix Inc Classifications & Recommendation:

Buy
100%

CorMedix Inc Price Target

Target Price $17.00
Price $10.33
Potential
Number of Estimates 5
5 Analysts have issued a price target CorMedix Inc 2025 . The average CorMedix Inc target price is $17.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend CorMedix Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CorMedix Inc stock has an average upside potential 2025 of . Most analysts recommend the CorMedix Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.00 31.88
100.00%

5 Analysts have issued a sales forecast CorMedix Inc 2024 . The average CorMedix Inc sales estimate is

$31.9m
Unlock
. This is
160.01% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$33.8m 175.39%
Unlock
, the lowest is
$30.8m 151.40%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $0.0 100.00%
2025
$114m 256.11%
Unlock
2026
$175m 54.55%
Unlock
2027
$256m 46.10%
Unlock
2028
$340m 32.66%
Unlock

The average CorMedix Inc net profit estimate is

$22.0m
Unlock
. This is
147.50% higher
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-52.7m 22.97%
2024
$22.0m 141.76%
Unlock

Net Margin

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -0.91 0.38
22.97% 141.76%
P/E 27.18
EV/Sales 18.24

The average CorMedix Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.38
Unlock
. This is
147.50% higher
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.91 22.97%
2024
$0.38 141.76%
Unlock

P/E ratio

Current -12.89 240.11%
2024
27.18 310.86%
Unlock

Based on analysts' sales estimates for 2024, the CorMedix Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

18.24
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
19.66
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 47.42 98.48%
2024
18.24 61.54%
Unlock
2025
5.12 71.92%
Unlock
2026
3.31 35.30%
Unlock
2027
2.27 31.55%
Unlock
2028
1.71 24.62%
Unlock

P/S ratio

Current 51.13 98.84%
2024
19.66 61.54%
Unlock
2025
5.52 71.92%
Unlock
2026
3.57 35.30%
Unlock
2027
2.45 31.55%
Unlock
2028
1.84 24.62%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today